These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7475937)

  • 1. Influence of antidepressant drugs administration on the morphine inhibitory effect in mice vasa deferentia.
    Moreno-Brea MR; Gibert-Rahola J; Micó JA
    Life Sci; 1995; 57(21):PL339-45. PubMed ID: 7475937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of morphine on the release of noradrenaline from the mouse vas deferens.
    Henderson G; Hughes J
    Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersensitivity to morphine of the transmurally stimulated vas deferens isolated from ethanol-pretreated mice.
    Tabach R; De Moraes S
    Eur J Pharmacol; 1992 Jun; 216(3):449-51. PubMed ID: 1330584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chronic morphine administration to mice on the contractile activity in vitro of the vas deferens without and with morphine.
    Martí MC
    Eur J Pharmacol; 1982 Mar; 78(4):439-47. PubMed ID: 6122589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens.
    Pertwee RG; Griffin G
    Eur J Pharmacol; 1995 Jan; 272(1):67-72. PubMed ID: 7713151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effects of presynaptic alpha-adrenoceptor agonists on contractions of guinea-pig ileum and mouse vas deferens in the morphine-dependent and withdrawn states produced in vitro.
    Gillan MG; Kosterlitz HW; Robson LE; Waterfield AA
    Br J Pharmacol; 1979 Aug; 66(4):601-8. PubMed ID: 37965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.
    Driessen B; Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Feb; 108(2):443-7. PubMed ID: 8383564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic drug treatment on the sensitivity of mouse vas deferens to drugs.
    McCulloch CR; Pollock D
    Eur J Pharmacol; 1985 Dec; 118(3):253-61. PubMed ID: 4085557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the inhibitory effect of morphine, pentobarbital and ethanol on the electrically evoked contractions of isolated mouse vas deferens.
    Saragai K; Kaneto H
    J Pharmacobiodyn; 1989 Sep; 12(9):558-65. PubMed ID: 2614644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.
    North RA; Vitek LV
    Br J Pharmacol; 1980 Mar; 68(3):399-405. PubMed ID: 7052335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine on electrically evoked contractions of the vas deferens in two congeneric rodent species differing in sperm competition intensity.
    Pound N
    Proc Biol Sci; 1999 Sep; 266(1430):1755-8. PubMed ID: 10518324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens.
    Berti F; Bruno F; Omini C; Racagni G
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):5-8. PubMed ID: 723970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium ions, morphine tolerance and noradrenergic transmission in the mouse vas deferens.
    Marshall I; Phillips DG; Nasmyth PA
    Eur J Pharmacol; 1981 Nov; 75(4):205-13. PubMed ID: 6274667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).
    Al-Kazwini SJ; Craig RK; Marshall I
    Br J Pharmacol; 1986 May; 88(1):173-80. PubMed ID: 3486688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic alpha-adrenoceptor blocking properties among tri- and tetra-cyclic antidepressant drugs.
    Harper B; Hughes IE
    Br J Pharmacol; 1979 Dec; 67(4):511-7. PubMed ID: 42458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens.
    Illes P; Zieglgänsberger W; Herz A
    Brain Res; 1980 Sep; 197(1):260-3. PubMed ID: 6249458
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.
    Hughes J; Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitability ot beta-endorphin, morphine and catecholamines of the vas deferens of the rat at different stages of development.
    Huidobro-Toro JP; Miranda H
    Eur J Pharmacol; 1981 Nov; 76(1):115-8. PubMed ID: 6274671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.